(Q90630542)

PubMed ID

32209811

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32209811%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

title

Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock (English)

1 reference

PubMed ID

32209811

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32209811%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

1 reference

1 reference

Jonathan H Chow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32209811%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Michael A Mazzeffi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32209811%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Michael T McCurdy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32209811%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

publication date

23 March 2020

1 reference

PubMed ID

32209811

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32209811%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

published in

Anesthesia & Analgesia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32209811%20AND%20SRC:MED&resulttype=core&format=json

Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans

27 May 2020

cites work

1 reference

12 December 2020

The acute respiratory distress syndrome

1 reference

12 December 2020

Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?

1 reference

12 December 2020

Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway.

1 reference

12 December 2020

1 reference

12 December 2020

Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.

1 reference

12 December 2020

Angiotensin II for the Treatment of Vasodilatory Shock

1 reference

12 December 2020

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.

1 reference

12 December 2020

Angiotensin converting enzyme defects in shock: implications for future therapy

1 reference

12 December 2020

Renin as a Marker of Tissue-Perfusion and Prognosis in Critically Ill Patients*

1 reference

12 December 2020

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.

1 reference

12 December 2020

Reversal of Vasodilatory Shock: Current Perspectives on Conventional, Rescue, and Emerging Vasoactive Agents for the Treatment of Shock

1 reference

12 December 2020

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock

1 reference

12 December 2020

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

1 reference

12 December 2020

10.1213/ANE.0000000000004825

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32209811%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 May 2020

COVIDWHO ID

covidwho-15426

0 references

1125907050

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32209811%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32209811%20AND%20SRC:MED&resulttype=core&format=json